| HIV Infection |
1 |
1 |
| Intravenous |
0 |
0.97 |
| Patient Safety |
0 |
0.79 |
| Biologic Therapy |
0 |
0.21 |
| Diarrhea |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Revenue and Practice Management |
0 |
0.11 |
| Adverse Effects |
0 |
0.07 |
| California |
0 |
0.07 |
| Clinical Research |
0 |
0.07 |
| Dizziness |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Immune Reconstitution |
0 |
0.07 |
| International Practice of Medicine |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |
| Nausea |
0 |
0.07 |
| Pharmacokinetics |
0 |
0.07 |